SGRY logo

SURGERY PARTNERS INC

SGRYNASDAQ
πŸ† #2028 by market capEarnings Nov 9 Β· PreUS Equity
$14.41β–Ό $0.28 (βˆ’1.91%)
πŸŒ™ After hours$14.41β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track SGRY
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 1.9%
7dβ–Ό 8.8%
14dβ–² 5.5%
30dβ–² 5.3%
ytdβ–Ό 6.7%
1yβ–Ό 34.2%
🏦Market Cap
$1.88B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+6.2%
Slowing
πŸ“ŠGross Margin
21.4%
Moderate
πŸ’΅FCF Margin
5.6%
Moderate
βš–οΈP/S Ratio
0.6x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$14.24 – $14.56
52-Week Range
$11.41 – $23.44
Volume
$5.66B
Avg Volume
$5.83B
Shares Outstanding
130.8M
Next Earnings
Oct 30, 2026

Fundamentals Snapshot

Annual Revenue
$3.31B
Last Q Revenue
$849M
P/E Ratio
-21.3
P/S Ratio
0.6x
EPS (TTM)
$-0.69
Dividend Yield
0.00%
Dilution (1yr)
+0.8%

Why Investors Own SGRY

  • βœ“High-growth profile β€” revenue up +0.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 48% gross margin and 17% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SGRY logo

SURGERY PARTNERS INC

SGRY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.3Bβ–² +6.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
23.1%β–Ό βˆ’3.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$390Mβ–² +11.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$196Mβ–Ό βˆ’6.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
127.2Mβ–² +0.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$3.8Bβ–Ό βˆ’$351M YoY
StockOtter Β· stockotter.space

About SURGERY PARTNERS INC

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilitiesβ€”specifically, 108 ambulatory surgical centers and 18 surgical hospitalsβ€”situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Ratings

β“˜
Consensus
Buy
18 analysts
Strong Buy5
Buy9
Hold4
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

Zacks Investment ResearchΒ·6d ago

Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term

Seeking AlphaΒ·6d ago

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment

I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also sim

GlobeNewsWireΒ·12d ago

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (β€œSurgery Partners” or the β€œCompany”), a leading short-stay surgical facility owner and operator, today announced it has completed

The Motley FoolΒ·26d ago

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares

The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.

Defense WorldΒ·Aug 30

6,241,503 Shares in Surgery Partners, Inc. $SGRY Purchased by BlackRock Inc.

BlackRock Inc. acquired a new position in shares of Surgery Partners, Inc. (NASDAQ: SGRY) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,24

Zacks Investment ResearchΒ·Aug 11

Likely ETF & Stock Winners From July Jobs Report

Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.